Upgrade to SI Premium - Free Trial

Moderna (MRNA) PT Raised to 'Street High' $108 at Oppenheimer

May 18, 2020 12:41 PM
Oppenheimer analyst Hartaj Singh raised the price target on Moderna (NASDAQ: MRNA) to $108.00 (from $62.00) while maintaining an Outperform ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change Momentum Movers Trader Talk

Next Articles